Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800017263Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of bailing jiaonang in asthma (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Asthma treatment step-down with combined medication and Asthma control level. Planned start Jan 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800017263.